Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 30 of GT Biopharma, Inc.'s SEC filings and found 16 warrant series, 4 convertibles, 1 equity line, 1 shelf registration, 5 S-1 registrations and 2 completed offerings on file for GTBP. The latest dilution event on file is a registration statement on Oct 9, 2026. Analysis updated Oct 29, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ICUSeaStar Medical Holding Corporation
GDTCCytoMed Therapeutics Limited Ordinary Shares
PHIOPhio Pharmaceuticals Corp.
PASGPassage Bio, Inc.
TVRDTvardi Therapeutics, Inc.
INTSIntensity Therapeutics, Inc.
INTIInhibitor Therapeutics, Inc.
CALCCalciMedica, Inc.
CLGNCollPlant Biotechnologies Ltd Ordinary Shares
INABIN8bio, Inc.
LSTALisata Therapeutics, Inc.
BLRXBioLineRX Ltd
PTNPalatin Technologies, Inc.
GUTSFractyl Health, Inc.
LTRNLantern Pharma Inc.